Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, the FDA issued a Warning Letter to VaVaVape, a tobacco product company, on March 2, 2023. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The letter falls under FDA tobacco product regulation, though the specific issuing office is not identified in the metadata provided. To understand the exact compliance issues and required corrective actions, review of the complete Warning Letter would be necessary.